.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint asks for inclusion of clients along with MASLD and dimension of liver end results in cardio-- kidney-- metabolic trials, when information propose mechanistically possible perks as well as scientific safety and security-- and also summarizes factors for test concept as well as governing approval.